SLS
Sellas Life Sciences Group Inc
11.30$
-2.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 64.3% | 51.0% | 88.0% | 81.4% | 90.7% | 84.0% | 91.5% | 91.2% | 95.1% | 96.0% | 97.4% | 98.0% | |
| 49.1% | 40.7% | 75.4% | 60.5% | 79.3% | 71.5% | 81.2% | 78.3% | 86.2% | 91.8% | 93.9% | 95.2% | |
| 49.1% | 40.7% | 75.4% | 60.5% | 79.3% | 71.5% | 81.2% | 78.3% | 86.2% | 91.8% | 93.9% | 95.2% | |
| 23.7% | 30.8% | 7.8% | 12.7% | 7.2% | 9.8% | 5.5% | 5.9% | 3.7% | 2.4% | 1.7% | 1.3% | |
| 147.3% | 228.3% | 60.4% | 80.7% | 40.0% | 51.3% | 20.6% | 19.1% | 11.5% | 9.5% | 5.9% | 5.3% | |
| 145.1% | 220.9% | 59.1% | 79.7% | 40.0% | 48.9% | 19.7% | 18.6% | 11.5% | 9.0% | 5.7% | 5.2% | |
| 5.8% | 7.2% | 2.0% | 3.5% | 2.2% | 2.8% | 1.6% | 1.8% | 1.2% | 0.7% | 0.5% | 0.4% | |
| 53.7% | 90.7% | 30.3% | 41.9% | 17.2% | 18.0% | 10.7% | 10.3% | 4.5% | 3.8% | 3.2% | 2.1% | |
| -47.3% | -128.3% | 39.6% | 19.3% | 60.0% | 48.7% | 79.4% | 80.9% | 88.5% | 90.5% | 94.1% | 94.7% | |
| -2,586.0% | -3,493.2% | -928.3% | -1,549.6% | -910.7% | -1,276.9% | -726.5% | -806.5% | -518.5% | -351.0% | -248.2% | -201.5% | |
| 350.7% | 495.3% | 183.4% | 381.2% | 257.5% | 380.8% | 251.1% | 305.1% | 210.3% | 195.4% | 151.1% | 130.1% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.